SurModics Inc. (NASDAQ:SRDX) VP Charles W. Olson sold 500 shares of the firm’s stock in a transaction that occurred on Friday, November 25th. The stock was sold at an average price of $26.02, for a total transaction of $13,010.00. Following the transaction, the vice president now directly owns 27,245 shares of the company’s stock, valued at $708,914.90. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Shares of SurModics Inc. (NASDAQ:SRDX) opened at 24.90 on Tuesday. The firm has a market cap of $325.89 million, a P/E ratio of 32.76 and a beta of 0.98. SurModics Inc. has a one year low of $17.45 and a one year high of $30.75. The firm’s 50-day moving average price is $26.64 and its 200 day moving average price is $26.23.

SurModics (NASDAQ:SRDX) last issued its quarterly earnings results on Wednesday, November 16th. The company reported $0.26 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.09 by $0.17. SurModics had a return on equity of 15.98% and a net margin of 13.99%. The firm had revenue of $18.20 million for the quarter, compared to analyst estimates of $16.09 million. During the same period in the previous year, the firm earned $0.30 earnings per share. The company’s revenue was up 4.6% compared to the same quarter last year. Analysts predict that SurModics Inc. will post $1.04 EPS for the current year.

Insider Buying and Selling by Quarter for SurModics (NASDAQ:SRDX)

COPYRIGHT VIOLATION WARNING: “SurModics Inc. (SRDX) VP Charles W. Olson Sells 500 Shares” was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another website, it was illegally stolen and reposted in violation of US & international trademark and copyright laws. The original version of this news story can be viewed at https://www.thecerbatgem.com/2016/11/29/surmodics-inc-srdx-vp-charles-w-olson-sells-500-shares.html.

A number of institutional investors have recently modified their holdings of SRDX. Prudential Financial Inc. raised its position in shares of SurModics by 1.0% in the second quarter. Prudential Financial Inc. now owns 46,622 shares of the company’s stock valued at $1,095,000 after buying an additional 460 shares during the period. Bank of Montreal Can acquired a new position in shares of SurModics during the second quarter valued at about $190,000. Gabelli Funds LLC raised its position in shares of SurModics by 2.4% in the second quarter. Gabelli Funds LLC now owns 128,626 shares of the company’s stock valued at $3,020,000 after buying an additional 3,000 shares during the period. Emerald Acquisition Ltd. acquired a new position in shares of SurModics during the second quarter valued at about $4,581,000. Finally, Ameriprise Financial Inc. raised its position in shares of SurModics by 6.7% in the second quarter. Ameriprise Financial Inc. now owns 65,348 shares of the company’s stock valued at $1,535,000 after buying an additional 4,132 shares during the period. 88.55% of the stock is currently owned by hedge funds and other institutional investors.

SRDX has been the subject of several analyst reports. Sidoti cut shares of SurModics from a “buy” rating to a “neutral” rating and set a $33.00 target price for the company. in a research note on Thursday, October 6th. Zacks Investment Research raised shares of SurModics from a “hold” rating to a “buy” rating and set a $32.00 target price for the company in a research note on Thursday, October 20th. Finally, Barrington Research cut shares of SurModics from an “outperform” rating to a “market perform” rating in a research note on Monday, November 21st.

About SurModics

SurModics, Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The Company operates through two segments: Medical Device and In Vitro Diagnostics. The Company is focused on to transform its medical device business from being a provider of coating technologies to offering whole product solutions to medical device customers.

5 Day Chart for NASDAQ:SRDX

Receive News & Stock Ratings for SurModics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SurModics Inc. and related stocks with our FREE daily email newsletter.